Nov 28, 2025 by Daniel FoelberRanking the Best "Magnificent Seven" Stocks to Buy for 2026. Here's My No. 4 Pick.The market is now convinced that Alphabet is a leader in artificial intelligence (AI).
Nov 28, 2025 by Keith SpeightsBlack Friday Sale for Income Investors: These Ultra-High-Yield Dividend Stocks Are Bargain BuysYou won't even have to get out of the house to take advantage of these bargains.
Nov 28, 2025 by Adria CiminoWhere Will CoreWeave Stock Be in 5 Years?The company's revenue more than doubled in the recent quarter.
Nov 28, 2025 by Daniel FoelberRanking the Best "Magnificent Seven" Stocks to Buy for 2026. Here's My No. 4 Pick.The market is now convinced that Alphabet is a leader in artificial intelligence (AI).
Nov 28, 2025 by Keith SpeightsBlack Friday Sale for Income Investors: These Ultra-High-Yield Dividend Stocks Are Bargain BuysYou won't even have to get out of the house to take advantage of these bargains.
Nov 28, 2025 by Keithen DruryPalantir's Co-Founder Just Dumped His Entire Nvidia Stake. Should Investors Follow Suit?Peter Thiel's track record is incredible. Should you follow his recent Nvidia stock sale?
Nov 28, 2025 by Adria CiminoWhere Will CoreWeave Stock Be in 5 Years?The company's revenue more than doubled in the recent quarter.
Nov 28, 2025 by Anthony Di Pizio1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $200 in December and Hold for the Long TermTechnologies like artificial intelligence and quantum computing are transforming the cybersecurity landscape.
Nov 28, 2025 by Neha ChamariaBlack Friday Sale: 3 Magnificent Dividend Stocks Down 12% to 24% to Buy and Hold For 5 YearsMake use of this big shopping day to buy these rock-solid dividend stocks with huge return potential.
Nov 28, 2025 by Sean WilliamsPrediction: Wall Street's Biggest Bubble Will Burst in 2026 (and I'm Not Talking About Artificial Intelligence)Headwinds are mounting for a hyped early stage technology that's still years away from being a needle mover.
Nov 28, 2025 by Rachel Warren3 Top REIT Dividend Stocks to Buy Right Now With $1,000 for Passive IncomeDon't overlook these REITs the next time you go stock shopping.
Nov 28, 2025 by Thomas NielIs Altria Group Too Cheap to Ignore at Today's Price?Shares of the Marlboro maker may have more room to fall before they hit deep-value territory.
Nov 28, 2025 by James Brumley3 Stocks That Turned $1,000 into $1 Million (or More)You just need to pick the right stock out of a field of many.
Nov 28, 2025 by Lawrence NgaIs Dutch Bros the Next Starbucks -- or the Next Shake Shack?Dutch Bros is still early in its journey -- and whether it brews into the next Starbucks or cools like Shake Shack will depend on how well it scales what makes it special.
Nov 28, 2025 by Maurie Backman3 Reasons You May Not Want to Claim Social Security at 70It's important to look beyond boosted monthly benefits.
Nov 28, 2025 by Thomas NielThis REIT Dividend King Could Secure Your Retirement With $1.5 MillionHeadquartered just outside our nation's capital, this REIT has increased its dividend during each of the past 58 years.
Nov 28, 2025 by Sean WilliamsThe No. 1 Holding of Retail Investors on Robinhood Was Just Dumped (Again!) by Billionaire Philippe Laffont of Coatue ManagementOne of Wall Street's most prominent billionaire money managers has been a persistent seller of the face of the artificial intelligence (AI) revolution.
Nov 28, 2025 by Lawrence NgaKrispy Kreme Stock Looks Cheap -- or Does It?This is a high-risk, but potentially high-reward turnaround story.
Nov 28, 2025 by Danny Vena, CPA2 Unstoppable Stock-Split Growth Stocks That Could Soar 51% and 64%, According to Wall StreetThese two investor-favorite stock-split stocks still have plenty of room to run.
Nov 27, 2025 by Motley Fool YouTubeLululemon: Can It Regain Its Mojo in a Competitive Market?Join us as we dissect Lululemon's stock performance and explore whether it can reclaim its former glory in the competitive athleisure market. Will it be a market beater or a missed opportunity?
Nov 27, 2025 by Jonathan PoncianoThis Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug ResultsOne clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
Nov 27, 2025 by Jonathan PoncianoBiotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% CrashA brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.
Nov 27, 2025 by George Budwell, PhD2 Unstoppable Growth Stocks I'd Buy NowBoth of these electric air taxi pioneers have sold off hard recently, creating a potential entry point for patient investors.
